TCL Archive Death On Saltz Regimen Prompt Groups To Suspend Accrual On Colon Cancer Trials. May 11, 2001
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Professional Societies: ASCO Seeks Balance In Roles As U.S., International Society May 23, 1997
TCL Archive NCI Awards $59M Contract For Key Project To consolidate Phase III Trial Administration October 29, 1999
